Skip to main content

Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia

Medically reviewed by Carmen Pope, BPharm. Last updated on April 24, 2025.

By Elana Gotkine HealthDay Reporter

THURSDAY, April 24, 2025 -- Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD), according to a study published online April 23 in Neurology.

Jeong-Yoon Lee, M.D., from Soonchunhyang University Seoul Hospital in South Korea, and colleagues conducted a nationwide population-based cohort study using data from the Korean National Insurance Service to examine whether MetS, defined according to established guidelines, and its individual components increase the risk for YOD, defined as dementia diagnosis before age 65 years.

Data were included for 1,979,509 participants; 8,921 (0.45 percent) developed YOD during an average follow-up of 7.75 years. The researchers found that MetS was associated with an increased risk for all-cause YOD, Alzheimer disease, and vascular dementia (adjusted hazard ratios, 1.24, 1.12, and 1.21, respectively). There were significant interactions noted with younger age (40 to 49 versus 50 to 59 years), female sex, drinking status, obesity, and depression.

"Our findings suggest that lifestyle changes to reduce the risk of metabolic syndrome, such as eating a healthy diet, exercising regularly, maintaining a healthy weight, quitting smoking, and reducing stress, may help reduce the risk of young-onset dementia," coauthor Minwoo Lee, M.D., Ph.D., of Hallym University Sacred Heart Hospital in Anyang, South Korea, said in a statement. "Future research that follows people over longer periods of time and uses brain scans to look for biomarkers of dementia is needed to confirm and expand upon our findings."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...

Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease

TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...

Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms

MONDAY, May 19, 2025 -- Among adults with elevated cardiometabolic risk, calorie restrictions and low-fat diets may reduce depressive symptoms, according to a review published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.